InnoCan Pharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1015 926 5 Ave SW, Calgary, Alberta, T2P...Phone Number
+972 5162104025Website
www.innocanpharma.comRevenue
$29.4 MillionStock Symbol
INNPFIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About InnoCan Pharma
Innocan Pharma specializes in innovative non-opioid solutions for chronic pain management and wellness, catering to both human and animal health markets. The company focuses on drug development, pre-clinical studies, and maintaining a robust regulatory pipeline to advance its offerings. Their portfolio also includes wellness products infused with CBD, aimed at improving overall well-being. Target clients include individuals seeking non-opioid pain management options and improved health outcomes.Explore more
InnoCan Pharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InnoCan Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if InnoCan Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at InnoCan Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if InnoCan Pharma is spiking on competitors!
InnoCan Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when InnoCan Pharma launches new products
Earning: See what the market has to say on InnoCan Pharma recently announced quarterly report
Click to see if InnoCan Pharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once InnoCan Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to InnoCan Pharma
Compare insights from companies similar to InnoCan Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InnoCan Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InnoCan Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InnoCan Pharma.
InnoCan Pharma financials insights
Gather financial insights about InnoCan Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$3.7M
2023
Share Placement
$1.2M
2026
Stock/Share Issuance
$200K
InnoCan Pharma Tech Stack
A closer look at the technologies used by InnoCan Pharma
Most Recent Scoops
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Executive Move
Executive Moves, Board of Directors
Project
Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
InnoCan Pharma News & Media
Innocan Pharma LPT-CBD is featured in Pain Medicine News
HERZLIYA, Israel and CALGARY, AB, May 6, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries is pleased to announce that its novel Liposomal Delivery Platform for...Innocan Pharma Announces Closing of Additional Debenture
HERZLIYA, Israel and CALGARY, AB, April 6, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its previously announced offering of an additional debenture of the Company (the...Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
HERZLIYA, Israel and CALGARY, AB, March 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an offering of a debenture of the Company (the "Debenture") to its largest...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding InnoCan Pharma
Sign Up For FreeTo access detailed company insights
Innocan Pharma specializes in innovative non-opioid solutions for chronic pain management and wellness, catering to both human and animal health markets. The company focuses on drug development, pre-clinical studies, and maintaining a robust regulatory pipeline to advance its offerings. Their portfolio also includes wellness products infused with C... Read More
